SEVERE HYPERCAPNIC RESPIRATORY FAILURE IN STATUS ASTHMATICUS WITH EXTREME VENTILATOR PRESSURES AND PERSISTENT BRONCHOSPASM: A CASE REQUIRING ECMO-LEVEL EVALUATION

Case Presentation: A 22-year-old female with severe persistent asthma presented with rapidly progressive dyspnea and near-silent chest following a rhinovirus-triggered upper respiratory infection. EMS and ED records described escalating work of breathing, SpO₂ 89%, HR ~130s, and profound hypercapnic respiratory failure with initial pH ~7.19 and pCO₂ >60 mmHg, later falling to pH 6.94 with pCO₂ 124 mmHg. She was emergently intubated using etomidate and rocuronium, and post-intubation ventilation revealed severe obstruction with dynamic hyperinflation, auto-PEEP 5–10 cm H₂O, and peak/plateau pressures >50 and >30 cm H₂O. Multiple ventilator modes (PC, VC, PRVC) produced tidal volumes as low as 50–150 mL despite inspiratory pressures up to 38 cm H₂O; best minute ventilation (~9–12 L/min) required VC mode with tidal volumes 350–400 mL and high FiO₂. Serial ABGs demonstrated persistent hypercapnia (pCO₂ 98–124 mmHg) and pH 6.9–7.1. Management included deep multimodal sedation, continuous neuromuscular blockade, continuous/intravenous bronchodilators, high-dose steroids, magnesium, terbutaline, epinephrine, theophylline, and Heliox. Labs revealed leukocytosis (20–27 ×10⁹/L), lactate up to 6.0 mmol/L, intermittent electrolyte abnormalities, and recurrent hypotension requiring vasopressors. Anisocoria prompted neuroimaging, which was negative. Persistent ventilatory failure led to early ECMO evaluation and transfer to an ECMO-capable center.

Discussion: Status asthmaticus is the most extreme asthmatic attack, marked by bronchoconstriction that does not respond, airway edema, and mucus plugging, resulting in dynamic hyperinflation, hypercapnia, and impaired gas exchange. Most exacerbations are treated with β-agonists and systemic corticosteroids; however, a small number progress to fatal respiratory failure. This patient’s extreme acidosis, massive CO₂ retention, and ongoing wheezing under paralysis exemplify refractory asthma with impending ventilatory collapse. Mechanical ventilation is challenging due to auto-PEEP, very high intrathoracic pressures, and barotrauma. Lung-protective measures, including low tidal volumes, reduced respiratory rates, and permissive hypercapnia, were employed to prevent further injury. Persistent hypercapnia and acidosis despite aggressive bronchodilators, sedation, paralysis, and hemodynamic support highlight the systemic strain from prolonged β-agonist exposure and ventilatory failure. Metabolic derangements, rising lactate, intermittent hypotension, and electrolyte fluctuations underscore the multisystem effects of extreme airway obstruction, emphasizing the need for vigilant physiologic monitoring. In refractory cases, ECMO should be considered early as a lifesaving bridge to protect the lungs from ventilator-induced injury while ensuring oxygenation.

Conclusions: This case illustrates the rapid deterioration and complexity of fulminant status asthmaticus, emphasizing early recognition of severe airflow obstruction, careful ventilator management, and aggressive multimodal therapy. Persistent hypercapnia, extreme airway pressures, and treatment-resistant bronchospasm highlight the importance of early ECMO evaluation when conventional therapy fails. Multidisciplinary collaboration among emergency, ICU, respiratory therapy, pharmacy, and ECMO teams is critical to prevent irreversible cardiopulmonary failure in severe asthma cases.